Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data

About this update from Revelation Biosciences, Inc.

SAN DIEGO, CA / ACCESS Newswire / September 9, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on rebalancing inflammation, wants to remind you of our September 10 th webcast at 8:30 am Eastern Time, which can be accessed here or to call in, please dial 888-506-0062 (toll free in the US), +1 973-528-0011 (if International) and use the participant access code 289672. We look forward to reviewing the data with you tomorrow morning. A copy of the original press release announcing data can be found here . A copy of the presentation to be reviewed can be found here . About Revelation Biosciences, Inc. Revelation Biosciences, Inc. is a clinical stage life sciences company focused on rebalancing inflammation using its proprietary formulation Gemini. Revelation has multiple ongoing programs to evaluate Gemini, including as a prevention for post-surgical infection, as prevention for acute kidney injury and the treatment of chronic kidney disease. For more information on Revelation, please visit https://www.revbiosciences.com . Company Contact Mike Porter Investor Relations Porter LaVay & Rose Inc. Email: [email protected] Chester Zygmont, III Chief Financial Officer Revelation Biosciences Inc. Email: [email protected] SOURCE: Revelation Biosciences, Inc. View the original press release on ACCESS Newswire

View stock analysis, news, and events for Revelation Biosciences, Inc.